MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
126.54%
Quick Ratio
108.82%
Unit: Million (M) dollars
Assets Breakdown
Finite Lived Intangible Assets N...
Goodwill
Accounts receivable, net
Others
Liabilities Breakdown
Additional paid-in capital
Accrued rebates
Other current liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
3,179
7,628
7,564
7,330
Short-term marketable debt securities
0
15
68
19
Accounts receivable, net
5,055
4,741
4,913
5,095
Inventories
1,953
1,914
1,774
1,785
Prepaid and other current assets
3,759
4,342
4,024
3,645
Total current assets
13,945
18,641
18,342
17,874
Property, plant and equipment, net
5,833
5,638
5,606
5,500
Long-term marketable debt securities
0
983
2,974
2,005
Intangible Asset Sofosbuvir
-
-
-
10,720
Axicabtageneciloleucel DLBCL
-
-
-
7,110
Trodelvy
-
-
-
11,730
Hepcludex
-
-
-
845
Other Intangible Assets
-
-
-
1,479
Finite Lived Intangible Assets Gross
-
-
-
31,884
Finite Lived Intangible Assets Net
14,032
14,082
14,678
-
Gross carrying amount
0
2,300
2,300
2,700
Gross carrying amount
-
-
-
34,584
Accumulated amortization
-
-
-
16,614
Intangible Asset Sofosbuvir
-
-
-
0
Axicabtageneciloleucel DLBCL
-
-
-
0
Trodelvy
-
-
-
0
Hepcludex
-
-
-
0
Other Intangible Assets
-
-
-
0
Finite
-
-
-
0
Foreign currency translation adjustment
0
0
0
0
Total Indefinite Lived Intangible Assets Excluding Goodwill
0
2,300
2,300
-
Intangible assets, net
14,032
16,382
16,978
17,970
Goodwill
8,314
8,314
8,314
8,314
Deferred tax assets
2,487
1,767
1,964
1,998
Other long-term assets
4,751
4,554
4,845
4,873
Total assets
49,362
56,278
59,023
58,533
Accounts payable
674
645
715
808
Accrued rebates
4,233
4,118
4,337
4,931
Current portion of long-term debt, net
2,414
1,313
2,807
2,806
Other current liabilities
3,699
3,399
3,953
3,752
Total current liabilities
11,020
9,476
11,813
12,298
Long-term debt, net
23,832
20,861
22,129
22,135
Long-term income taxes payable
943
918
896
866
Deferred tax liabilities
333
392
402
597
Other long-term liabilities
1,490
1,200
1,165
1,182
Common stock, par value 0.001 per share 5,600 shares authorized 1,241 shares issued and outstanding
1
1
1
1
Additional paid-in capital
9,532
9,305
8,932
8,678
Accumulated other comprehensive income
95
78
39
36
Retained earnings
2,200
14,131
13,730
12,825
Total gilead stockholders equity
11,829
23,515
22,703
21,540
Noncontrolling interest
-84
-84
-84
-84
Total stockholders equity
11,744
23,431
22,618
21,456
Total liabilities and stockholders equity
49,362
56,278
59,023
58,533
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Finite Lived
Intangible Assets Net
$14,032M
(-11.56%↓ Y/Y)
Accounts receivable, net
$5,055M
(5.73%↑ Y/Y)
Prepaid and other
current assets
$3,759M
(29.67%↑ Y/Y)
Cash and cash
equivalents
$3,179M
(-38.20%↓ Y/Y)
Inventories
$1,953M
(7.01%↑ Y/Y)
Intangible assets, net
$14,032M
(-24.42%↓ Y/Y)
Total current assets
$13,945M
(-5.25%↓ Y/Y)
Goodwill
$8,314M
(0.00%↑ Y/Y)
Property, plant and
equipment, net
$5,833M
(6.85%↑ Y/Y)
Other long-term
assets
$4,751M
(17.86%↑ Y/Y)
Deferred tax assets
$2,487M
(-8.60%↓ Y/Y)
Total assets
$49,362M
(-11.41%↓ Y/Y)
Total liabilities and
stockholders equity
$49,362M
(-11.41%↓ Y/Y)
Long-term debt, net
$23,832M
(7.64%↑ Y/Y)
Total stockholders
equity
$11,744M
(-40.05%↓ Y/Y)
Total current
liabilities
$11,020M
(-1.51%↓ Y/Y)
Other long-term
liabilities
$1,490M
(15.50%↑ Y/Y)
Long-term income taxes
payable
$943M
(9.78%↑ Y/Y)
Deferred tax liabilities
$333M
(-48.93%↓ Y/Y)
Noncontrolling interest
-$84M
(0.00%↑ Y/Y)
Total gilead
stockholders equity
$11,829M
(-39.87%↓ Y/Y)
Accrued rebates
$4,233M
(0.43%↑ Y/Y)
Other current
liabilities
$3,699M
(3.15%↑ Y/Y)
Current portion of
long-term debt, net
$2,414M
(-13.97%↓ Y/Y)
Accounts payable
$674M
(15.81%↑ Y/Y)
Additional paid-in capital
$9,532M
(13.92%↑ Y/Y)
Retained earnings
$2,200M
(-80.57%↓ Y/Y)
Accumulated other
comprehensive income
$95M
(627.78%↑ Y/Y)
Common stock, par value
0.001 per share 5,600...
$1M
(0.00%↑ Y/Y)
Buy us a coffee
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)